Scendea is pleased to announce that our Asia-Pacific Regional Business Development Manager, Daniel Berg, will be attending Bio Connections Australia 2026. Get in touch to arrange a meeting with Daniel during the event: scendea.com/contact
Scendea's Asia-Pacific Regional Business Development Director, Daniel Berg, is having a great time in Sydney at the ARCS Annual Conference 2026!
Get in touch to book a last-minute meeting, today: scendea.com/contact
-
#ARCS2026
BIO Asia-Taiwan is one of the region’s leading life sciences events. If you are attending and would like to discuss your product development goals, Daniel would welcome the opportunity to meet. Search 'Scendea' on the partnering platform, or get in touch: scendea.com/contact
The FDA have issued a draft guidance to assist manufacturers, applicants, and other stakeholders in developing human GT products incorporating ex-vivo and in vivo GE of human somatic cells (GE products. Get in touch to learn more: scendea.com/contact
Scendea’s Compliance Division work alongside your team to custom build and strength your QMS to ensure it is compliant, practical, scalable and aligned with your day-to-day operations. Book a complimentary call with our Compliance experts, today: scendea.com/contact
Our Director, Paul Cronin, will be attending the DIA Global Annual Meeting in Philadelphia from June 14 - 18. If you are attending DIA and would like to arrange a meeting, get in touch: scendea.com/contact
-
#DIAGlobal#DIAMeeting
A reminder that Scendea's Regional Business Development Manager, Asia-Pacific, Daniel Berg, will be attending the 2026 ARCS Australia Annual Conference in Sydney from June 10 - 12 at ICC Sydney, Darling Harbour.
Secure a meeting here: scendea.com/contact
-
#ARCS2026
A reminder that our latest whitepaper on implementing effective control strategies in biopharmaceutical manufacturing is now available to download. If you haven’t already, you can read the full whitepaper here:
scendea.com/articles/impleme…
-
#Biopharma#CMC